Your contact

Elisabeth Harbich

Project Management Start-up Support

From science to venture

Are you a biomedical founding team ready to take your idea to the next level? Join our BioEntrepreneur Bootcamp 2026 –  – a biomedical start-up business training program in Munich designed to help you develop, validate, and accelerate your business concept.

Date: 3 February 2026 to 26 March 2026

Time:  Seven weeks, Tuesday-Thursday, full day

Location: Hybrid (virtually & BioM, Am Klopferspitz 19a, 82152 Martinsried-Planegg)

Costs: free for pre-seed teams from Bavaria

Pricing

  • Start-up teams from Bavaria 99 € 
  • Pre-seed / start-ups international 199 €

NO SHOW FEE:  for all teams 99 €

Application Period:  3 - 26 November 2025

Over seven weeks (sessions running from Tuesday to Thursday), participants engage in:

  • 9 on-site days in Munich
  • 12 full-day online sessions
  • Plus, off-site teamwork on validation, strategy, and pitching etc.

Please apply via the following link: Application form BioM Bootcamp

Who should apply?

Pre-seed biomedical teams with an innovative idea in:

  • Drugs and therapies 
  • Biotechnology diagnostics, prediction, or prognosis platforms
  • Drug discovery & development technologies platforms

What you gain:

  • Validate your concept with industry experts and potential partners
  • Strengthen your team and business roadmap
  • Learn about funding, IP, regulations, and deal-making essentials
  • Connect with mentors, investors, and pharma leaders

Why join?

  • Learn from top experts and gain hands-on expertise in business strategy, IP, financing, regulation, and partnering
  • Work with mentors throughout the program 
  • Pitch to an expert jury at the final Demo Day
  • Expand your stakeholder network 
  • Make sure your business model meets real market needs

Because every great idea deserves a great launchpad!

More details on the application process are coming soon – stay tuned!


More on the topic

09.01.2026
Ovo Labs announces world’s first rejuvenation of human eggs – hope for millions of aspiring parents
Ovo Labs, a pioneering biotechnology company from Oberschleißheim/Munich, has presented first-time efficacy data for its lead therapeutic EmbryoProtect 1 (EP1) at the UK’s largest fertility…
Ovo Labs announces world’s first rejuvenation of human eggs – hope for millions of aspiring parents
18.12.2025
BioM to Co-Host the 4th Session of Creative Destruction Lab (CDL) in Munich
BioM, together with its partner DEEP, the  Institute for Deep Tech Innovation at ESMT Berlin, will co-host in Munich the 4th yearly session of Creative Destruction Lab (CDL), an…
Bio<sup>M</sup> to Co-Host the 4th Session of Creative Destruction Lab (CDL) in Munich
16.12.2025
T-CURX raises 20 millions US-dollars series A to advance non-viral CAR-T cancer therapies
T-CURX announced a 20 Mio USD Series A first closing led by BiomedVC to fund pipeline of clinical-stage CAR-T programs and advance proprietary non-viral in vivo CAR-T platform. T-CURX GmbH,…
T-CURX raises 20 millions US-dollars series A to advance non-viral CAR-T cancer therapies